As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >UK, its market, its Brexit, where are we ? You need some answers …
Sign up!The French Embassy in the United Kingdom and Business France are teaming up with Genopole to offer you a webinar Visa4Biotech dedicated to a leading country in the life sciences: markets, innovations, business creation, Brexit.
Introduction
Laurent Pépin, Business and Partnership Director, GenopoleTech Ecosystem Landscape
Alice Woda, Digital Attachée, Economic department, French EmbassyThe Biotech Ecosystem Overview
Introduction – Claire Guellier, Trade Development Adviser UK, Healthcare & Biotech, Business FrancePublic Funds for Innovation
Dora Meredith, European and Global Manager, Innovate UKCatapult Cell and Gene Therapy Centre: presentation
David Sexton, Business Development Manager, CGT CatapultExperience Sharing of a French Biotech in the UK
Frédéric Garzoni, Director and Co-founder, ImophoronThe “Visa4biotech” events have the primary objective of heightening the international awareness of the biocluster’s citizens.
These events provide the businesses with concrete information on the regulatory issues (intellectual property, patents, etc.) and growth opportunities for the fields of biotechnology and health in regions or countries with emerging and/or particularly innovative markets.
